Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 61-72 of 4,306
Other study type icon
RecruitingNCT01409109

Database Registry for Neural Network Biomarkers in Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 60 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06071858

Enhanced Coordinated Specialty Care for Early Psychosis

This study is looking at whether Care Coordination can help people with psychosis or bipolarity. Participants take part in Care Coordination and complete follow-up assessments.

Multiple locations, including Belmont
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityBehavioral
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia, Bipolarity
Device study icon
RecruitingISRCTN24746936

CONNECT: using electronic devices (e.g. smartphones, smartwatches) to predict relapse of psychosis

This observational study is following people with Psychosis or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 16 Years to 100 Years
Countries
United Kingdom
Sponsor
University of Manchester
Condition
Schizophrenia
Other study type icon
RecruitingISRCTN16976551

Development of a guideline for the early detection of psychosis in long-term care facilities

This observational study is following people with in nursing homes with moderate and severe psychotic symptoms or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Belgium
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
Belgium
Sponsor
University College Odisee
Condition
Schizophrenia
Behavioral study icon
RecruitingISRCTN79060696

gameChange VR: automated virtual therapy to help people with psychosis reduce anxious avoidance of everyday situations

This study is looking at whether UKCA marked gameChange VR therapy can help people with Agoraphobic avoidance in with a diagnosis of psychosis or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 16 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia
Behavioral study icon
RecruitingISRCTN11089633

Testing the clinical effectiveness of Social Recovery Therapy for people with psychosis and social disability

This study will test Social Recovery Therapy for people living with psychosis and social disability. The ISRCTN record shows it as not yet recruiting.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Sussex Partnership NHS Foundation Trust
Condition
Schizophrenia
Drug study icon
RecruitingEUCTR 2021-000350-26

A double blind, randomized, placebo-controlled, adaptive 24-week Phase IIb trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia....

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Kazanlik
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Bulgaria, Poland, Romania, ...
Sponsor
Oryzon Genomics, S.A.
Condition
Schizophrenia
Drug study icon
RecruitingEUCTR 2021-001333-38

Cognitive effects of adjuntive Vortioxetine in early Schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Sevilla
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Spain
Sponsor
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)
Condition
Schizophrenia
Drug study icon
RecruitingNCT07493551

A Bioequivalence Study of PP3M in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Beijing
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.